Prospective Phase II Trial of Neoajuvant Tislelizumab Combined with Chemotherapy for Initially Unresectable Stage IIIA/N2 Non-small Cell Lung Cancer
Latest Information Update: 03 Oct 2024
At a glance
- Drugs Tislelizumab (Primary) ; Platinum complexes
- Indications Non-small cell lung cancer; Squamous cell cancer
- Focus Therapeutic Use
Most Recent Events
- 03 Oct 2024 New trial record